Prostate Ca immunotherapy induces T-cell response – ModernMedicine
|
Prostate Ca immunotherapy induces T-cell response
ModernMedicine Results of a study conducted to further elucidate the mechanism of action of sipuleucel-T (Provenge) as treatment for advanced prostate cancer provide fairly convincing demonstration that the autologous cellular immunotherapy agent induces T-cell … |
